文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Status and hotspot analysis of Qingfei Paidu Decoction for the prevention and treatment of COVID-19 based on bibliometric analysis.

作者信息

Zhang Huifang, Liu Yang, Shang Xiyu, Cao Yuqing, Li Jiajia, Chen Guangkun, Ji Xinyu, Zhang Lei, Fan Yipin, Ma Yan

机构信息

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.

Shaanxi Academy of Traditional Chinese Medicine, Xi'an, China.

出版信息

Front Pharmacol. 2024 Jul 31;15:1422773. doi: 10.3389/fphar.2024.1422773. eCollection 2024.


DOI:10.3389/fphar.2024.1422773
PMID:39144631
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11322107/
Abstract

BACKGROUND: Qingfei Paidu Decoction (QFPDD) has played an important role in the prevention and treatment of COVID-19 infection in China. The present study aims to perform an econometric analysis and visualization of the literature on the treatment of COVID-19 with QFPDD in the Chinese databases and English databases. METHODS: Six databases including such as Chinese databases CNKI, VIP, CBM, WANFANG as well as English databases PubMed, Web of Science were searched for publications related to the prevention and treatment of COVID-19 with QFPDD. The institutions, authors, keywords of each publication were cisualized using the software of CiteSpace. RESULTS: A total of 187 literature on the prevention and treatment of novel coronavirus infection with QFPDD were included, of which 145 (77.5%) were in Chinese and 42 (22.5%) were in English. Those publications were written by 926 authors from 383 institutions. There were 78 theoretical studies (41.7%), 63 clinical studies (33.7%), and 46 basic studies (24.6%). The cooperative institutions with the core of "Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences" and "Shanghai University of Chinese Medicine Cross Academy of Science" have been formed, and two core teams with "Wang Yanping" and "Zhang Weidong" have been formed. The keyword analysis showed that the research mainly focuses on pathologic pathogenesis, clinical efficacy, adverse reactions, integrated Chinese and western medicine therapy, network pharmacology research. CONCLUSION: QFPDD has attracted worldwide attention, mechanism research and clinical research may become a future development trend. Therefore, in-depth basic research and clinical studies with large samples and multi-center cooperation should be carried out to provide high-level evidence-based evidence for the prevention and treatment of COVID-19 with QFPDD.

摘要

相似文献

[1]
Status and hotspot analysis of Qingfei Paidu Decoction for the prevention and treatment of COVID-19 based on bibliometric analysis.

Front Pharmacol. 2024-7-31

[2]
Bibliometric analysis and key messages of integrating Chinese and Western Medicine for COVID-19.

Heliyon. 2024-3-8

[3]
A bibliometric analysis of research related Chinese Medicine in the prevention and treatment of corona virus disease 2019.

Heliyon. 2022-11

[4]
Research Advance on Qingfei Paidu Decoction in Prescription Principle, Mechanism Analysis and Clinical Application.

Front Pharmacol. 2021-1-27

[5]
Treatment Effect of Qingfei Paidu Decoction Combined With Conventional Treatment on COVID-19 Patients and Other Respiratory Diseases: A Multi-Center Retrospective Case Series.

Front Pharmacol. 2022-7-13

[6]
Effect of Qingfei Paidu decoction combined with Western medicine treatments for COVID-19: A systematic review and meta-analysis.

Phytomedicine. 2022-7-20

[7]
Construction of a multi-tissue compound-target interaction network of Qingfei Paidu decoction in COVID-19 treatment based on deep learning and transcriptomic analysis.

J Bioinform Comput Biol. 2024-8

[8]
An integrative analysis of Qingfei Paidu Decoction for its anti-HCoV-229E mechanism in cold and damp environment based on the pharmacokinetics, metabolomics and molecular docking technology.

Phytomedicine. 2023-1

[9]
Identification of phytochemicals in Qingfei Paidu decoction for the treatment of coronavirus disease 2019 by targeting the virus-host interactome.

Biomed Pharmacother. 2022-12

[10]
Computational Analysis Illustrates the Mechanism of Qingfei Paidu Decoction in Blocking the Transition of COVID-19 Patients from Mild to Severe Stage.

Curr Gene Ther. 2022

引用本文的文献

[1]
A Direct Relationship Between 'Blood Stasis' and Fibrinaloid Microclots in Chronic, Inflammatory, and Vascular Diseases, and Some Traditional Natural Products Approaches to Treatment.

Pharmaceuticals (Basel). 2025-5-12

本文引用的文献

[1]
Wen-Yi and Chinese medicine: Why we need to pay attention?

Sci Bull (Beijing). 2024-6-15

[2]
Knowledge, attitudes, and practices about COVID-19 pandemic: a bibliometric analysis.

Front Public Health. 2023

[3]
Knowledge mapping of COVID-19 and dentistry: A bibliometric analysis.

Front Public Health. 2022

[4]
Treatment Effect of Qingfei Paidu Decoction Combined With Conventional Treatment on COVID-19 Patients and Other Respiratory Diseases: A Multi-Center Retrospective Case Series.

Front Pharmacol. 2022-7-13

[5]
Scientometric assessment of scientific documents published in 2020 on herbal medicines used for COVID-19.

J Herb Med. 2022-9

[6]
Mechanism of Microbial Metabolite Leupeptin in the Treatment of COVID-19 by Traditional Chinese Medicine Herbs.

mBio. 2021-10-26

[7]
Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis.

Front Pharmacol. 2021-8-12

[8]
Association between use of Qingfei Paidu Tang and mortality in hospitalized patients with COVID-19: A national retrospective registry study.

Phytomedicine. 2021-5

[9]
Association of Overlapped and Un-overlapped Comorbidities with COVID-19 Severity and Treatment Outcomes: A Retrospective Cohort Study from Nine Provinces in China.

Biomed Environ Sci. 2020-12-20

[10]
Telemedicine and the Use of Korean Medicine for Patients With COVID-19 in South Korea: Observational Study.

JMIR Public Health Surveill. 2021-1-19

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索